Friday, April 18, 2008

“This sort of puts the spotlight on the greed angle of the business,” said Dr. Robert R. Clancy

In case the quote above didn't make it clear, here's another article about insurance companies, including our own Caremark and Medco. It seems that sometimes they're the exclusive distributors for expensive drugs. When they become the only distributors, the prices inexplicably skyrocket. As one executive explained, "We did some market research,” Mr. Cartt said. Talking to pediatric neurologists and others about various pricing options “gave us some comfort that the strategy would work, and physicians would continue to use the drug, and payers would pay,” he said. “The reality was better than we expected.”

No comments:

Post a Comment